Mysuru's JSS Science and Technology University (JSSSTU), in collaboration with the Indian National Space Promotion and Authorization Centre (IN-SPACe), is set to launch the JNANAM (JSS Nanosatellite for Applications in Medicine) student satellite project. This initiative aims to study the effects of microgravity and space radiation on drug samples, potentially leading to the development of more stable and effective medications for astronauts and broader pharmaceutical applications.
The framework memorandum of understanding (MoU) between JSSSTU and IN-SPACe encompasses support from the Indian Space Research Organisation (ISRO) and its various centers. This collaboration will enable students and faculty at JSSSTU to design, realize, and test the JNANAM cubesat. Post-launch support from ISRO is also included in the agreement.
ISRO's Role and Satellite Capabilities
The MoU grants JSSSTU access to ISRO facilities for satellite design and testing on a non-exclusive basis. Furthermore, ISRO will provide post-launch support for the in-orbit satellite. The launch is tentatively scheduled for the first quarter of 2025.
Scientific Objectives and Impact
JNANAM's primary mission is to conduct a spectroscopy experiment in space. This experiment will analyze how microgravity and space radiation affect drug samples. The resulting data is expected to provide valuable insights for scientists and the pharmaceutical industry, facilitating the creation of drugs that are more stable and suitable for use by space travelers. This research could also have implications for improving drug formulations and storage on Earth.
